Denied Agent Orange Claim? CUE and Refiling
Is a second look worth it? Quick check
- You were denied a condition that VA later added to the 38 CFR § 3.309(e) presumptive list.
- You were denied on a location or date basis that has since been expanded (Blue Water Navy, Thailand, Laos, Cambodia, Guam).
- The decision granted the condition but assigned an effective date later than your original claim.
- The decision applied the wrong regulation or ignored evidence that was in the file at the time.
Any one of these being true is reason enough to have the decision reviewed.
Which lane fits which problem
- (): the lane when new and relevant evidence exists, or when a regulatory change means the should now be readjudicated. This is the usual path for a condition added to the list after a denial.
- (): a senior reviewer looks at the same evidence for a difference of opinion or a clear error. No new evidence allowed.
- (): review by a , with or without a hearing or additional evidence, depending on the docket chosen.
- motion: available against a decision that is already final. The standard is deliberately narrow — the error must be undebatable and must have manifestly changed the outcome. Disagreement about how evidence was weighed is not CUE.
Why effective dates drive the value
A grant is only half the outcome. The determines how far back retroactive payment runs, and in long-running herbicide cases that can span years. Under the Nehmer class-action rules, when VA adds a disease to the herbicide presumptive list, certain previously denied claims are readjudicated with an effective date tied back to the date of the earlier rather than the date of the new decision.
That mechanism is specific to covered herbicide claims and has its own eligibility conditions. It is worth having any pre-list herbicide denial reviewed specifically for effective-date exposure, because the retroactive component is frequently larger than the go-forward monthly increase.
What a review of an old denial looks at
- The exact reason for denial stated in the original — location, diagnosis, , or evidence sufficiency.
- Whether the regulation cited in that decision still reads the same way today.
- Whether the condition was subsequently added to the presumptive list, and when.
- Whether the location or date window was later expanded by statute.
- Whether the correct was assigned on any later grant.
What this does not mean
Nothing here predicts an outcome. Regulatory expansion creates an opportunity to have a readjudicated; it does not guarantee a grant, a particular rating, or a particular . The purpose of a review is to identify whether a viable lane exists and what evidence it would require.
Common problems with refiling old herbicide claims
- ×Filing a brand-new claim instead of a Supplemental Claim, which can cost the earlier effective date.
- ×Filing a CUE motion over evidence weighing, which does not meet the CUE standard.
- ×Accepting a grant without checking whether the effective date should reach back further.
- ×Choosing Higher-Level Review when new evidence is the actual missing piece (HLR does not accept it).
- ×Missing the appeal window on a recent decision and turning an easy lane into a CUE problem.
Frequently Asked Questions
References & sources
- 38 CFR § 3.105(a) — revision of decisions (CUE) — eCFR
- 38 CFR § 3.816 — awards under Nehmer v. VA — eCFR
- 38 CFR § 3.400 — effective dates — eCFR
Useful Tools & Topics
Have questions about your specific case?
Every veteran's facts are different. A free initial consultation with a VA-Accredited Claims Agent can tell you whether your matter is a fit for representation — and what the right next step looks like either way.
Disclaimer: This page is for educational purposes only and does not constitute legal advice. Oakridge Claims is a private business and is not affiliated with, endorsed by, or operated by the U.S. Department of Veterans Affairs. No guarantees of outcomes are made. Each claim is decided on its individual facts.
Related guides
Agent Orange Secondary Conditions
Conditions caused by a presumptive primary — neuropathy, kidney disease, ED — can be rated separately under 38 CFR § 3.310.
If Your BDD Claim Is Denied or Underrated
AMA review options after a BDD rating decision — Higher-Level Review, Supplemental Claim, and Board appeal — with the deadlines and effective-date rules that apply.
Compare Appeals Lanes
Side-by-side comparison of Higher-Level Review, Supplemental Claim, and Board appeal — speed, evidence rules, and outcomes.
Korean DMZ Agent Orange Claims
Korea-era veterans who served in or near the DMZ may qualify for the same presumption Vietnam veterans receive.

